J&J | JNJ - Interest Income

Stock Price
238.41
Daily Change
-2.56 -1.06%
Monthly
-1.72%
Yearly
58.94%
Q2 Forecast
235.72

J&J reported $2.12 in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Abbott USD 77M 6M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Baxter International USD 10M 4M Sep/2025
Bayer EUR 130M 38M Sep/2025
Becton, Dickinson and Co. USD 4M 1000K Dec/2025
Biogen USD 31.6M 700K Sep/2025
Boston Scientific USD 4M 3M Dec/2022
Dexcom USD 32.7M 4.7M Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Globus Medical USD 815K 3.08M Dec/2024
Hologic USD 0.79 18.9M Dec/2025
Insulet USD 8.6M 1.5M Sep/2025
Integra LifeSciences USD 4.98M 272K Sep/2025
Intuitive Surgical USD 95.5M 6.8M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Medtronic USD 114M 23M Jan/2025
Merck USD 96M 27M Sep/2025
Merit Medical Systems USD 3.62M 146K Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 2.51M 1.68M Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025
Zoetis USD 26M 7M Sep/2025